GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)

19.82
Delayed Data
As of Apr 18
 -0.465 / -2.29%
Today’s Change
17.89
Today|||52-Week Range
21.30
+5.71%
Year-to-Date
Clovis Focuses on Rubraca Label Expansion, Competition Stiff
Apr 18 / Zacks.com - Paid Partner Content
Clovis Stalls Mid-Stage Rubraca Study for Bladder Cancer
Apr 15 / Zacks.com - Paid Partner Content
Emergent's (EBS) Chikungunya Vaccine Positive in Phase II Study
Apr 17 / Zacks.com - Paid Partner Content
Merck's Keytruda Gets FDA Nod for Expanded Lung Cancer Group
Apr 12 / Zacks.com - Paid Partner Content
Axsome's AXS-05 Meets Goal in Phase II Study, Shares Up
Apr 16 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New Deal
Apr 12 / Zacks.com - Paid Partner Content
Novartis' (NVS) BLA for Ophthalmology Drug Accepted by FDA
Apr 16 / Zacks.com - Paid Partner Content
Novartis to Market Rizmoic Through Sandoz, Spins Off Alcon
Apr 11 / Zacks.com - Paid Partner Content
Would You Loan Me $20? Character in Management
Apr 15 / GuruFocus News - Paid Partner Content
AstraZeneca/Merck's Lynparza Wins EU Nod for Breast Cancer
Apr 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close20.29
Today’s open19.82
Day’s range19.82 - 19.82
Volume244
Average volume (3 months)6,282
Market cap$99.7B
Data as of 11:27am ET, 04/18/2019

Growth & Valuation

Earnings growth (last year)+143.10%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+5.72%
P/E ratio13.8
Price/Sales2.30
Price/Book17.72

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$41.1B
Annual profit (last year)$4.8B
Net profit margin11.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Iain James Mackay
Corporate headquarters
Brentford, Greater London

Forecasts